Variant report
Variant | esv1850902 |
---|---|
Chromosome Location | chr2:49654581-49661323 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1544915 | chr2:49654581-49654582 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs561886681 | chr2:49654583-49654584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529061100 | chr2:49654584-49654585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149521902 | chr2:49654596-49654597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552007349 | chr2:49654607-49654608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569050662 | chr2:49654610-49654611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533303547 | chr2:49654611-49654612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552561007 | chr2:49654636-49654637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10204612 | chr2:49654658-49654659 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs147212418 | chr2:49654672-49654673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138967231 | chr2:49654702-49654703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568570067 | chr2:49654712-49654713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535669118 | chr2:49654721-49654722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528007496 | chr2:49654723-49654724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10193709 | chr2:49654727-49654728 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs10181357 | chr2:49654736-49654737 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs539746915 | chr2:49654747-49654748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112527429 | chr2:49654756-49654757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184037139 | chr2:49654780-49654781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186577019 | chr2:49654797-49654798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540255914 | chr2:49654814-49654815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561604445 | chr2:49654836-49654837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573725020 | chr2:49654873-49654874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs72888636 | chr2:49654926-49654927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200633571 | chr2:49654941-49654942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376953624 | chr2:49654942-49654943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146753657 | chr2:49654943-49654944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs398071290 | chr2:49654945-49654946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562708614 | chr2:49654988-49654989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533238217 | chr2:49655007-49655008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189891737 | chr2:49655022-49655023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555430334 | chr2:49655043-49655044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560474735 | chr2:49655046-49655047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528473320 | chr2:49655055-49655056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547019994 | chr2:49655081-49655082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142911229 | chr2:49655102-49655103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535955094 | chr2:49655107-49655108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550848598 | chr2:49655168-49655169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74965582 | chr2:49655182-49655183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200776737 | chr2:49655192-49655193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539708124 | chr2:49655195-49655196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49653600-49654600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:49654000-49655000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr2:49654000-49655200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:49654200-49655000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |